Menu Search
Equities

Trajan Group Holdings Ltd

TRJNF:PKC

Trajan Group Holdings Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Trajan Group Holdings Limited is an Australia-based developer and manufacturer of analytical and life sciences products and devices. The portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Company operates through two segments: Analytical Products and Life Science Solutions. The Analytical Products segment is involved in the designing, manufacturing, distribution and selling of analytical components and consumables. Life Science Solutions segment is involved in the designing, manufacturing, distribution and selling of pathology, automation workflow solutions, micro sampling devices, testing and data analysis. Its solutions include analytical, analytical services, sampling, pathology, and automation. Its pathology products include ZERO Exposure NBF containers, Series 1 Adhesive Microscope Slides, Series 1 Frosted Microscope Slides, and Series 2 Adhesive Microscope Slides.

  • Revenue in AUD (TTM)158.50m
  • Net income in AUD-1.68m
  • Incorporated2011
  • Employees653.00
  • Location
    Trajan Group Holdings LtdRingwoodMELBOURNE 3134AustraliaAUS
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.